Medipharm Labs Corp T.LABS

RE:NDA - ANDA

[AADADuato]

Here's the current list of CBD based trials that I could find. 

The joint arthritis one stands out to me as I've found labs CBD formula illuminates my knee arthritis/ joint pains I get every once in a while. 

Current CBD Clinical Trials

The following CBD trials are the most up to date known to ClinicalTrials.gov. If you would like to showcase a clinical study on this page, contact our team.

A Vaccine Trial For Healthy Women Between 16-40

NCT05085366

A Cytomegalovirus (CMV) Investigational Vaccine Clinical Trial for Healthy Women Age 16 to 40. Compensation included.

Conditions: Healthy Volunteers, Healthy

Phase: NA

Register Interest

COVID Booster Vaccine Trial

NCT05329220

A clinical trial for adults 65+ focused on a booster vaccine, called ABNCoV2, to help protect adults against COVID-19.

Conditions: Healthy, Healthy Aging, Healthy Volunteer Study, COVID-19 (Healthy Volunteers)

Phase: 3

Cannabidiol, Morphine, Pain

NCT04030442

The purpose of the proposed study is to investigate the interaction of cannabidiol (CBD) and morphine effects on pain sensitivity. Cannabidiol is a cannabinoid (similar to cannabis, or marijuana) present in marijuana that alters some of the effects of marijuana.

Conditions: CBD, Chronic Pain

Phase: Phase 1

CBD-Microglia PET Study

NCT04398719

This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

Conditions: CBD, Healthy

Phase: Early Phase 1

RCT of CBD for Anxiety in Advanced Breast Cancer

NCT04482244

This research study is investigating use of a single dose of cannabidiol (CBD) to help manage anticipatory anxiety in participants with advanced breast cancer poised to undergo computed tomography (CT) or positron emission tomography (PET) to assess tumor burden. The name of the study drug(s) are: - Cannabidiol (CBD)

Conditions: Advanced Breast Cancer, Anxiety, CBD

Phase: Phase 2

Cannabidiol and Management of Endometriosis Pain

NCT04527003

The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) in patients with endometriosis. It is believed that CBD will improve both pain and quality of life. The study will last a total of 12 weeks and involve several onsite visits in addition to daily pain assessments.

Conditions: Endometriosis, CBD, Pelvic Pain

Phase: Phase 3

Topical CBD in Joint Arthritis

NCT04611347

Rationale: CBD is commonly being used as an over-the-counter treatment for arthritis-related pain, however no clinical trial has been performed to establish efficacy. Hypothesis: CBD is more effective than placebo for relieving pain and improving patient-reported outcomes for thumb basal joint arthritis. Study Design: The study design with be a double-blind, randomized controlled trial with crossover. Treatment will be blinded to the subjects and investigators. Patients will be randomly assign ...

Conditions: CBD, Hand Osteoarthritis

Phase: Phase 2

Synthetic CBD as a Therapy for COVID-19

NCT04686539

The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.

Conditions: Covid19, CBD

Phase: Phase 1

 

The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management as Well as Effectiveness in Reduction of Opioid Use: The CBD Will be Delivered Via Oil Droplets and Topical Cream Not Containing THC

NCT04729244

The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) from Hemp Oil in patients with Chronic pain, anxiety and insomnia. It is believed that CBD will improve pain anxiety and sleep quality and reduce opioid use. The study will last a total of 4 weeks and involve onsite visits in addition to weekly pain assessments.

Conditions: CBD, Pain, Chronic, Anxiety, Insomnia, Opioid Use

Phase: Phase 1

 

Methodology for Developing an Occlusal Appliance With CBD Active Carrier

NCT04775030

Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients

Conditions: Temporomandibular Disorder, Myofascial Pain, Cannabis, Electromyography, Occlusal Appliance, CBD

Phase: Phase 2/3

Sex Differences in Neural Response to Cannabidiol

NCT04777643

This is a randomized, double-blind, within-subjects, cross-over design to assess neural changes following a single dose of cannabidiol (CBD) (600mg) versus placebo among healthy female volunteers.

Conditions: CBD, Neural Responses

Phase: Early Phase 1

Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task

NCT04778644

Cannabidiol (CBD) is another cannabis plant derivative for which, like THC, there has been extensive research. Unlike THC however, CBD is non-intoxicating and non-psychedelic. CBD has antipsychotic effects. Logically, if CBD opposes THC effects, it may be a potential antipsychotic treatment. The purpose of this pilot research is to show target engagement of the hippocampus with the study drug (CBD versus placebo) in patients who have been diagnosed with schizophrenia, schizoaffective disorder, o ...

Conditions: CBD

Phase: Phase 1/2